IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.

Slides:



Advertisements
Similar presentations
What Causes Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes? Charles A. Reasner, MD Professor of Medicine University of.
Advertisements

ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University.
Insulin Signaling – Insulin Resistance Elmus G. Beale, Professor Texas Tech University Health Sciences Center Paul L. Foster School of Medicine PhD, Baylor.
DM Dewasa EVA DECROLI. Problems Increased of prevalence Cronic complications ex. Diabetic Foot Problems Prevention, primer, secunder tertier.
Hormonal Responses to Exercise Chapter 5. Neuroendocrinology Endocrine Glands –Release messengers: hormones Hormones –Circulate in blood –Affect tissue.
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Therapy of Type 2 Diabetes Mellitus: UPDATE
Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes ADA and AACE Guidelines: Room For Improvement.
Regulating Blood Sugar Islets of Langerhans groups of cells in the pancreas beta cells produce insulin alpha cells produce glucagon.
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stanley Schwartz.
Diabetes mellitus. Normal endocrine pancreas 1 million microscopic clusters of cells 1 million microscopic clusters of cells Β,α,δ,PP cells Β,α,δ,PP cells.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Current Therapy for Type II Diabetes. New ADA Guidelines- 4/20/12 Inzucchi, Diabetologia 4/20/12 SU most prominent- First, reading L to R Added back.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stan Schwartz MD,FACP.
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & early DM Part 4 Stan Schwartz MD, FACP, FACE.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.
The Road To Metabolic syndrome
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & Early DM Part 5 Stan Schwartz MD, FACP, FACE.
© 2013 Eli Lilly and Company Managing insulin therapy in Insulin resistance Speaker name and affiliation Prescribing information is available on the last.
Cardiovascular & Metabolic Complications of Cushing’s Syndrome Presented by: Saeed Behradmanesh, MD Internist, Endocrinologist.
Diabetes Mellitus Type 2
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Practical Implementation as a Discussion with the Patient Practical Use of SGLT-2 Inhibitors in T2DM: Clinical Pearls- Perlas de Sabiduria Stan Schwartz.
Insulin Resistance Progression to Diabetes Part 3.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
Bromocriptine QR The Biologic Clock. ADAPTIVE Insulin Resistance MAL-ADAPTIVE Insulin Resistance Insulin resistance begets insulin resistance: hyperinsulinemia.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Body Weight and Insulin Sensitivity Negative Correlation Insulin resistance may have evolved to prevent excessive weight gain BMI by CountyType II Diabetes.
CV Risk of SU and Insulin
The β-Cell Centric Classification of DM
β-Cell Centric Classification of Diabetes:
Once Upon a Time, Insulin Resistance was Adaptive… but Not Today
Beta-Cell Classification of Diabetes and the Egregious Eleven: Logic for Newer Algorithms/ Processes of Care The Role of Newer Anti-Diabetes Medications.
Chapter 7 Metabolic syndrome
Unified Theory of Diabetes and All Its Complications
Hormones Impacting Food Seeking Behavior
Treatment of Type 2 Diabetes: Pathophysiology Conclude: do so without Hypoglycemia or Visceral Fat Weight Gain 1.
Blood glucose levels and obesity
Regulating Blood Sugar
Volume 14, Issue 2, Pages (August 2011)
המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.
6.6 – Hormones, homeostasis and reproduction
In Metabolic Syndrome Hyperinsulinism Creates the Vicious Cycle: Increased MAP-kinase pathway Circulation. 2005;111: Metabolic Syndrome A Comprehensive.
The β-Cell Centric Classification of DM
Simplistic Inflammatory and Non-Inflammatory Effects of Insulin Resistance on B-Cell Function IAPP boosts islet macrophage IL-1 in type 2 diabetes : Nature.
White adipose tissue (HFD)
What do I remember? What is the effect of chronically elevated blood glucose levels on blood vessels? What cardiovascular diseases are a consequence of.
THE ENDOCANNABINOID SYSTEM AND CARDIOMETABOLIC RISK
Therapy of Type 2 Diabetes Mellitus: UPDATE
Prediabetes in youths: mechanisms and biomarkers
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
An Integrated View of Immunometabolism
Potential cellular mechanisms for activating inflammatory signaling
Learning Objective To be able to:
Volume 14, Issue 2, Pages (August 2011)
Once Upon a Time, Insulin Resistance was Adaptive… but Not Today
Curtis 2002/p47/c1/para5, p48/Table2
Presentation transcript:

IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor of Medicine, U of Pa. Part 2

Insulin Resistance a.Increased liver production sugar b.Decreased peripheral Glucose Uptake c.Increased production FFA from Adipose tissue (alternate fuel source) 1.Normal Response to Hibernation, Migration, Periods of Food lack!! BUT ALSO, Normal DIURNAL VARIATION IN INSULIN SENSITIVITY 2. Centrally Induced IR Exacerbated by: obesity, high fat diets, high CHO diets, abnormal sleep cycle, decreased exercise, 3. Also Associated with Abnormal Gut Microbiome

And OCCURS DIURNALLY as well Adaptive Mala-adaptive Exacerbated by: obesity, high fat diets, high CHO diets, abnormal sleep cycle, decreased exercise

ADAPTIVE IR MAL-ADAPTIVE IR

Poor Diet/ Inactivity--Walking the dog Courtesy Jim Sowers

HI FAT, Hi CHO Diet Suppress dopamine surge in SCN AM Obesity, Dec. Exer, abn. Sleep cycles

Implications for Therapy  Treat Central Mechanisms IR  Treat Peripheral IR- fat, liver, muscle  Treat Inflammation  Treat Biome

Insulin Resistance a.Increased liver production sugar b.Decreased peripheral Glucose Uptake c.Increased production FFA from Adipose tissue (alternate fuel source) 1.But potential for Maladaptive Effects of IR on Body if A. Biologic Clock Dysfunction B Peripheral IR causes HYPERINSULINEMIA- increases MAP-kinase pathway- cytokines, etc inc ASCVD risk factors C. Visceral Adipose tissue- 1. excessive FFA release, decrease b-cell function= lipotoxicity in genetically susceptible perrson, inc. risk/severity DM 2. adipocytokines increase inflammation, endothelial dysfunction

Insulin Roles Based on Nature of Insulin Receptors Signaling Pathways